Skin Microbiota – A Novel Target for Promoting Burn Wound Healing

Review article discussing
the wound microbiome and Amicapsil

Treatment of venous leg ulcers with Amicapsil

“Amicapsil healed my venous leg ulcers and changed my life.”

“From 4 weeks of absolute hell – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

NH ( patient)

SertaSil for veterinary wound treatment

SertaSil for veterinary wound care

Effective in treating severe infections, including infections not responding to antibiotics and antiseptics.

Treatment of wounds and pressure ulcers in persons with spinal cord injury

Amicapsil-SCI

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis.

Certified Quality Management System

ISO 13485:2016 is an international Quality Management System standard for manufacturers of medical devices. Willingsford Ltd. is certified according to this standard for the design, development and manufacture of wound care products. All our procedures are regularly externally audited and inspected (announced and unannounced) by the independent and impartial organisation, Eurofins, who is accredited by the European Commission as a Notified Body and whose certification and inspection services are furthermore accredited by FINAS, the Finnish Accreditation Service.

ISO 13485 is quality management certification specifically in relation to medical devices for humans.

Our internal analytical methods and tests are in accordance with the standards and guidelines of The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH.

Manufacturing and Packaging is performed in Class V clean and environment controlled conditions.

Certified Quality Management System

Amicapsil and Amicapsil-SCI on NHS Supply Chain

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

January 5’th, 2024 – MPPT clinical study published in Frontiers in Medicine